Natural Capsules Limited has set September 2, 2026 as the record date for its Extraordinary General Meeting (EGM) scheduled for September 9, 2026. Shareholders on record as of this date will be eligible to vote on the proposed ₹10 crore preferential allotment. The capital raise aims to strengthen working capital requirements and fund capital expansion, including the acquisition or establishment of new units.

The Board of Directors approved the proposal on August 12, 2026. The issue is structured into two components: equity shares and convertible warrants, both priced at ₹160 per unit. Promoter Sunil Laxminarayan Mundra is the sole proposed allottee for the entire tranche.

Issue Structure

The total raise of ₹10 crore is divided as follows:

The equity shares will be fully paid-up at the time of allotment. The warrants are fully convertible into equity shares on a one-to-one basis within 18 months of allotment.

Warrant Terms

The warrant structure requires an upfront payment of ₹40 (25% of the issue price) at subscription. The remaining ₹120 (75%) is payable upon exercise of the conversion right. If the warrants are not exercised within the 18-month tenure, the entitlement expires, and the upfront amount paid stands forfeited by the company. The warrants do not carry voting rights until converted.

Shareholding Impact

As of June 30, 2026, promoters held 50.92% of the company’s equity. Post-issue, assuming full conversion of warrants, promoter holding is projected to rise to 53.70%. Sunil Laxminarayan Mundra’s individual stake is expected to increase from 5.79% to 11.12%.

Natural Capsules Limited announced the resignation of Mr. Pramod Kasat from his position as Independent Director at Natural Biogenex Private Limited, a material unlisted subsidiary of the company. The departure becomes effective immediately on August 17, 2026.

The company cited professional commitments as the reason for Mr. Kasat's decision to step down from the board. This disclosure was made pursuant to Regulation 30(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Resignation Details

Mr. Kasat tendered his resignation to the Board of Directors of Natural Biogenex Private Limited. In his resignation letter, he thanked the board and management for the opportunity to serve and wished the company continued success.

The company's compliance officer, Akshay Dutta, confirmed that the requisite details and a copy of the resignation letter have been enclosed with the exchange filings. Natural Capsules Limited has requested the stock exchanges to take this intimation on record.